OEGSTGEEST, Netherlands, April 20, 2023 /PRNewswire/ — ISA Pharmaceuticals, B.V., a clinical stage biotech company developing immunotherapies to treat cancers and infectious diseases, is pleased to announce that it will be participating and presenting in person, at the following…